Allogene Therapeutics announces CEO succession plan

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. ABBV
4. MU
5. META
6. ACN
7. NVDA
8. BLZE
9. IBM
10. PRIM

Go back to Allogene Therapeutics announces CEO succession plan
(NASDAQ: ALLO) Delayed: 2.07 -0.03 (1.43%)
Previous Close $2.10    52 Week High $ 
Open $2.03    52 Week Low $ 
Day High $2.17    P/E N/A 
Day Low $2.03    EPS $ 
Volume 3,666,499